Organisational changes at Hirslanden Bern

By bringing together all three Hirslanden Bern hospitals under a single management team, the hospitals' range of services will in future be more targeted and coordinated around the hub-spoke model. In addition, more efficient management structures will ensure that existing synergies between hospitals can be better utilised moving forward. 

Dr Daniel Lüscher, currently Hospital Manager for Hirslanden Klinik Beau-Site and Salem-Spital, will be taking on responsibility for Klinik Permanence too as of 1 April 2022. Daniel Lüscher, a graduate in economics and business administration, also holds an Executive Master of Human Resources Management from the University of Applied Sciences and Arts Northwestern Switzerland FHNW, an Executive Master of Business Administration specialising in Health Service Management from Bern University of Applied Sciences, and a Doctor of Business Administration (DBA) from Kalaidos University of Applied Sciences Zurich and Middlesex University London. 

Klinik Permanence's current co-directors, Dr med Julia Beel and Claudine Jungo, will be appointed as deputy directors of the three Hirslanden Bern hospitals, responsible for strategic projects, and will actively shape the further development of Bern as part of a successful job share. Both have held managerial positions at Hirslanden Bern for many years and are well versed in its strategic alignment. 

Comprehensive, integrated medical care 

The merger of Klinik Beau-Site and Salem-Spital in Bern and Klinik Permanence in Bern West will create a comprehensive medical network with a clear focus on excellent integrated care, covering primary care, treatment in specialised areas and highly specialised medicine. OPERA Bern, the outpatient surgical unit that Hirslanden is opening this year at Nordring, Bern, will also be joining the network. 

Stéphan Studer, Chief Operating Officer of the Hirslanden Group says: "I'd like to thank Claudine Jungo, Julia Beel and Daniel Lüscher for their commitment and combined contributions to the well-being of the people of Bern in this new phase of Hirslanden Bern. Our ambition to improve the quality of life of all people along the entire treatment and care path will make great strides thanks to this reorganisation." 

Daniel Lüscher, Hospital Manager of the three Hirslanden Bern hospitals from 1 April 2022 added: "We want to be the main point of reference on health issues for the people of Bern, for both inpatient and outpatient treatment, or even acute medical diagnosis and treatment. From prevention to healing, we want to be there for people, all the time - both physically and digitally".

About Hirslanden

Hirslanden is committed to high-quality, responsible and efficiently integrated healthcare that focuses on the needs of the individual. Working together with private and public cooperation partners, the Hirslanden Group prioritises ongoing development of the Continuum of Care concept. From birth to old age, from prevention to healing, Hirslanden is always there, both physically and digitally. 

Hirslanden stands out from the rest of the market as a service provider with first-class medical and service quality, which is guaranteed by highly qualified independent specialists with years of experience who offer excellent care and services. Interdisciplinary medical centres of expertise, specialised institutes and competent cooperation partners enable optimal, personalised diagnosis and treatment, regardless of case complexity, in both inpatient and outpatient contexts. 

The Hirslanden Group operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 4 outpatient surgical units, 18 radiology institutes and 5 radiotherapy institutes. The Group has 2,314 partner doctors and 10,711 employees, 479 of whom are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. In the 2020/21 financial year, the Group generated a turnover of CHF 1,796 million (including CHF 12.6 million in cantonal COVID-19 compensation payments). As at 31 March 2021, 107,401 patients were being treated by the Group for a total of 461,004 inpatient days. In insurance terms, the patient mix consisted of 51 % basic, 28.8 % semi-private, and 20.2 % privately insured patients. The Hirslanden Group was formed in 1990 through the merger of several hospitals. Since 2007, it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.